Full-Year Revenue Growth
Fiscal 2025 revenue of $183.6M, up 13% year-over-year (10% ex-ResMetrics contribution), exceeding the high end of guidance.
Adjusted EBITDA Expansion
Adjusted EBITDA rose 20% year-over-year to $26.7M for FY2025, with adjusted EBITDA margin expanding to 14.5% from 13.7% a year earlier.
Strong Quarterly Performance
Q4 2025 revenue $50.6M (+13% YoY; +9% sequential), Q4 adjusted EBITDA $9.2M (adjusted EBITDA margin >18%), exceeding the high end of quarterly guidance.
High Free Cash Flow Conversion & Balance Sheet Strength
Generated $22M free cash flow in 2025 and $19M free cash flow after distributions (representing >70% conversion of adjusted EBITDA). Net cash position approx. $29.1M (cash $36.7M less debt $7.6M) and total liquidity ~ $61M (undrawn revolver availability $24.4M).
Successful Acquisition and Integration Progress (ResMetrics)
Acquired ResMetrics July 31, 2025; contributed $5.2M revenue in five months (Q4 contribution $2.9M). Commercial integration completed in U.S., lab IT systems upgraded, plan to centralize U.S. lab/manufacturing in Tulsa midyear; identified cost savings and revenue synergies.
Product Commercialization & New Market Wins
Multiple technology deployments and commercial wins: first Terrus AICV installation in Canada, StageSaver adoption and Repeat Precision growth, RapidTrace on-site tracer, Luminate samplers, SmartProp tracer expansion, and Raytec Propex sliding sleeve expected for deepwater Gulf of America later in the year.
Geographic Expansion
Revenue growth in U.S., Canada and international markets in 2025; orders from two new customers in Dutch sector of the North Sea; first well in Middle East using fracturing systems completed in 2025 and Repeat Precision sales in Middle East.
Improved Profitability & Tax Recognition
Net income improved to $23.7M (EPS $8.65) for FY2025 from $6.6M prior year, aided by release of deferred tax valuation allowances ($11.5M impact), and Q4 net income $15.0M (EPS $5.34) including $9.8M tax benefit.
2026 Guidance & Capital Allocation
Full-year 2026 guidance: revenue $184M–$194M, adjusted EBITDA $26M–$29M; targeting >50% adjusted EBITDA to free cash flow conversion and free cash flow after distributions $12M–$16M; gross capex guidance of $1.5M–$2.0M.